Cypherpunk Technologies Sees Unusually High Options Volume (NASDAQ:CYPH)

Cypherpunk Technologies (NASDAQ:CYPH) saw unusually large options trading on Friday. Stock investors purchased 4,236 put options on the company. This represents an increase of 104% compared to the average daily volume of 2,075 put options.

Cypherpunk Technologies Stock Down 3.7%

CYPH traded down $0.09 during trading on Friday, hitting $2.19. The company’s stock had a trading volume of 5,265,259 shares, compared to its average volume of 3,954,247. The firm has a market capitalization of $235.46 million, a P/E ratio of 3.90 and a beta of 0.33. Cypherpunk Technologies has a twelve month low of $0.27 and a twelve month high of $3.70. The stock’s fifty day moving average price is $0.91 and its 200-day moving average price is $0.86.

Cypherpunk Technologies (NASDAQ:CYPH) last announced its quarterly earnings data on Wednesday, August 12th. The company reported $0.18 EPS for the quarter.

Insider Activity

In related news, Director Thomas Dietz sold 20,000 shares of Cypherpunk Technologies stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $1.72, for a total value of $34,400.00. Following the transaction, the director directly owned 132,500 shares of the company’s stock, valued at $227,900. The trade was a 13.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 3.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Cypherpunk Technologies

A number of large investors have recently bought and sold shares of CYPH. Millennium Management LLC bought a new stake in Cypherpunk Technologies in the fourth quarter valued at $37,000. LPL Financial LLC bought a new position in shares of Cypherpunk Technologies during the 4th quarter worth about $38,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Cypherpunk Technologies during the 4th quarter worth about $44,000. Sequoia Financial Advisors LLC bought a new position in shares of Cypherpunk Technologies during the 4th quarter worth about $56,000. Finally, HighTower Advisors LLC acquired a new stake in shares of Cypherpunk Technologies in the 4th quarter valued at about $59,000. 30.46% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CYPH has been the subject of several analyst reports. Weiss Ratings upgraded shares of Cypherpunk Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, August 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $1.60 price objective on shares of Cypherpunk Technologies in a research note on Thursday, August 27th. Finally, Wall Street Zen upgraded shares of Cypherpunk Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Cypherpunk Technologies currently has a consensus rating of “Hold” and an average price target of $1.60.

About Cypherpunk Technologies

Cypherpunk Technologies Inc, previously known as Leap Therapeutics, Inc, is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion.

DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies.